• Customer Receipts of $1,847K for the 3 months to March-26 up 25% on PCP
• Operating and investing cashflow of ($500K) reduced 50% from the PCP
• Group Cashflow of ($908K) for the nine months to March-26 improves 26% from the PCP

Global Health Limited (ASX: GLH) has released its Appendix 4C Cash Flow Report for the quarter ended 31 March 2026, and the accompanying Quarterly Business Activity Report. The financial highlights include customer receipts of $1,847K for the 3 months to March-26, up 25% on the prior corresponding period (PCP). Operating and investing cashflow improved materially from ($1,005k) in the March-25 quarter to ($500k) in the March-26 quarter, a $505k or 50% reduction in cash burn. Group cashflow for the nine months improved from ($1,234k) in the 9 months to March-25 to ($908k) in the 9months to March-26 - a $326k (26%) improvement. Customer receipts for the 9-months to March 2026 were $7,013k, up $1,323k (23%) from $5,690k in the prior corresponding period, demonstrating sustained customer revenue growth. Operating cashflow improved from ($1,549k) to ($860k) representing a $689k (45%) reduction in cash burn for the 9-month period. Staff costs for the 9-months fell $867k (20%) to $3,491K, consistent with the cost reduction observed in the March quarter alone. Net operating and investing cashflow improved from ($1,544k) to ($882k), a $662k (43%) improvement for the 9-month period, reflecting the favourable operating cashflow movement.

The forecast is for sustainable profitable operations and positive cashflow from July 2026.

The productivity gains from incorporating AI across internal development and support workflows will enable further expense reductions. Applying AI to Customer Acquisition Costs (CAC) and introducing value-add AI features for customers is expected to increase Average Revenue Per User (ARPU). In combination, this is expected to result in sustainable profitable operations and positive cashflow from July 2026.